JTC Inc. (KOSDAQ:950170)
South Korea · Delayed Price · Currency is KRW 4,265.00
0.00 (0.00%)
At close: Sep 18, 2026
JTC Inc. Revenue
JTC Inc. had revenue of 46.38B KRW in the quarter ending May 31, 2026, a decrease of -51.87%. This brings the company's revenue in the last twelve months to 251.75B, down -21.56% year-over-year. In the fiscal year ending February 28, 2026, JTC Inc. had annual revenue of 301.73B, down -2.23%.
Revenue (ttm)
251.75B
Revenue Growth
-21.56%
P/S Ratio
0.82
Revenue / Employee
645.50M
Employees
414
Market Cap
206.11B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Feb 28, 2026 | 301.73B | -6.89B | -2.23% |
| Feb 28, 2025 | 308.62B | 158.63B | 105.76% |
| Feb 29, 2024 | 149.99B | 114.18B | 318.86% |
| Feb 28, 2023 | 35.81B | 21.84B | 156.35% |
| Feb 28, 2022 | 13.97B | -4.20B | -23.12% |
| Feb 28, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 29, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| EASY BIO,Inc. | 525.04B |
| TC Materials | 379.52B |
| SENA Technologies | 198.98B |
| Boditech Med | 174.78B |
| DAE HWA Pharmaceutical | 148.75B |
| Korea Information Certificate Authority | 144.18B |
| Galaxia Moneytree | 137.18B |
| OptiCore | 31.61B |